CRISPR Advances Cancer Treatment
Scientists have developed a new technique using CRISPR tools to identify genetic mutations in cancer cells, then activate the process of destroying their genetic material and inducing cell death. This opens up prospects for treating certain tumors more precisely and effectively. The technique relies on an enzyme called Cas12a2, which detects mutations associated with cancer, utilizing a DNA fingerprint-based discrimination mechanism to recognize and target infected cells without affecting healthy ones. Studies have shown that this system can target mutations that are difficult to treat with traditional drugs, especially in solid tumors. Research is focused on enhancing the immune system's ability to reach and attack the tumor more effectively. The research is still under development, with some CRISPR-based therapies entering clinical trials. However, these are still in early stages, with the major challenge being ensuring safety and achieving precise targeting of lesions without causing unintended damage.
Notice: This Is an AI-Generated Summary
Comments (0)